Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium

Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium

US Patent 10383916 · Granted Aug 20, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gene therapy for eosinophilic disorders2025
Treatment of brain cancers using central nervous system mediated gene transfer o2024
p63 inactivation for the treatment of heart failure2024
p63 inactivation for the treatment of heart failure2024
Oxidation-resistant AAT gene therapy2024
Treatment of brain cancers using central nervous system mediated gene transfer o2024
Genetic modification of the AAV capsid resulting in altered tropism and enhanced2023
p63 inactivation for the treatment of heart failure2022
p63 inactivation for the treatment of heart failure2022
Adenoassociated viral mediated persistant anti-VEGF therapy for ovarian cancer2021
Methods and pharmaceutical compositions for the treatment and the prevention of 2019
Gene therapy to prevent reactions to allergens2019